Champions Oncology PE Ratio 2006-2020 | CSBR

Current and historical p/e ratio for Champions Oncology (CSBR) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Champions Oncology PE ratio as of June 01, 2020 is 0.00.
Champions Oncology PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-06-01 9.55 0.00
2020-01-31 7.59 $-0.03 0.00
2019-10-31 5.23 $-0.09 0.00
2019-07-31 6.47 $-0.09 0.00
2019-04-30 9.08 $0.01 0.00
2019-01-31 12.23 $-0.03 0.00
2018-10-31 12.38 $-0.01 0.00
2018-07-31 8.00 $-0.04 0.00
2018-04-30 4.34 $-0.14 0.00
2018-01-31 3.82 $-0.30 0.00
2017-10-31 3.20 $-0.42 0.00
2017-07-31 2.84 $-0.46 0.00
2017-04-30 2.65 $-0.66 0.00
2017-01-31 4.75 $-0.74 0.00
2016-10-31 1.58 $-0.89 0.00
2016-07-31 1.96 $-1.13 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.114B $0.027B
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.202B 37.57
Takeda Pharmaceutical (TAK) Japan $61.479B 10.77
Astellas Pharma (ALPMY) Japan $33.697B 0.00
Eisai (ESALY) Japan $23.132B 0.00
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $13.984B 0.00
Grifols, S.A (GRFS) Spain $13.015B 16.18
Catalent (CTLT) United States $12.040B 46.54
Neurocrine Biosciences (NBIX) United States $11.586B 53.54
Ionis Pharmaceuticals (IONS) United States $7.831B 41.64
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
Orion OYJ (ORINY) Finland $7.628B 34.18
IPSEN SA ADR (IPSEY) France $6.677B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.602B 10.57
United Therapeutics (UTHR) United States $5.191B 9.84
Evotec AG (EVTCY) Germany $4.079B 0.00
Hypermarcas (HYPMY) Brazil $3.882B 0.00
Nektar Therapeutics (NKTR) United States $3.862B 0.00
ChemoCentryx (CCXI) United States $3.859B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.281B 358.22
PTC Therapeutics (PTCT) United States $3.188B 0.00
FibroGen (FGEN) United States $2.980B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.607B 10.71
Cronos Group (CRON) Canada $2.278B 65.30
Sage Therapeutics (SAGE) United States $1.855B 0.00
Pacira BioSciences (PCRX) United States $1.851B 37.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.782B 0.00
USANA Health Sciences (USNA) United States $1.780B 18.26
Corcept Therapeutics (CORT) United States $1.735B 17.20
Xencor (XNCR) United States $1.724B 0.00
Heron Therapeutics (HRTX) United States $1.652B 0.00
Zogenix (ZGNX) United States $1.612B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.593B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.551B 11.87
Akebia Therapeutics (AKBA) United States $1.516B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.458B 15.71
Portola Pharmaceuticals (PTLA) United States $1.409B 0.00
Karyopharm Therapeutics (KPTI) United States $1.352B 0.00
Translate Bio (TBIO) United States $1.303B 0.00
Tilray (TLRY) Canada $1.228B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.170B 0.00
Indivior (INVVY) United States $1.052B 13.06
Enanta Pharmaceuticals (ENTA) United States $1.030B 45.97
Endo (ENDP) Ireland $0.887B 1.37
ImmunoGen (IMGN) United States $0.816B 0.00
Collegium Pharmaceutical (COLL) United States $0.757B 0.00
Molecular Templates (MTEM) United States $0.709B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.694B 0.00
Aerie Pharmaceuticals (AERI) United States $0.652B 0.00
Ardelyx (ARDX) United States $0.652B 0.00
Radius Health (RDUS) United States $0.587B 0.00
Trillium Therapeutics (TRIL) Canada $0.566B 0.00
Harpoon Therapeutics (HARP) United States $0.544B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.541B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.537B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.485B 0.00
DURECT (DRRX) United States $0.459B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.456B 17.82
Catalyst Pharmaceuticals (CPRX) United States $0.446B 10.77
Flexion Therapeutics (FLXN) United States $0.441B 0.00
Organogenesis Holdings (ORGO) United States $0.438B 0.00
Calithera Biosciences (CALA) United States $0.410B 0.00
MEI Pharma (MEIP) United States $0.387B 0.00
Ocular Therapeutix (OCUL) United States $0.376B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.315B 0.00
Lannett Co Inc (LCI) United States $0.309B 6.77
TherapeuticsMD (TXMD) United States $0.307B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
Rafael Holdings (RFL) United States $0.273B 0.00
CASI Pharmaceuticals (CASI) United States $0.266B 0.00
Redhill Biopharma (RDHL) Israel $0.251B 0.00
KalVista Pharmaceuticals (KALV) United States $0.201B 0.00
VAXART, INC (VXRT) United States $0.199B 0.00
PROFOUND MEDICL (PROF) Canada $0.198B 0.00
OptiNose (OPTN) United States $0.198B 0.00
Xeris Pharmaceuticals (XERS) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 24.87
Jounce Therapeutics (JNCE) United States $0.184B 4.38
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
IMV INC (IMV) Canada $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.164B 0.00
Altimmune (ALT) United States $0.144B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.130B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.112B 0.00
Recro Pharma (REPH) United States $0.107B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Sundial Growers (SNDL) Canada $0.091B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
Heat Biologics (HTBX) United States $0.086B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
CTI BioPharma (CTIC) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Onconova Therapeutics (ONTX) United States $0.070B 0.00
Nivalis Therapeutics (ALPN) United States $0.069B 0.00
Biomerica (BMRA) United States $0.064B 0.00
Iterum Therapeutics (ITRM) Ireland $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
MediWound (MDWD) Israel $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.09
Opiant Pharmaceuticals (OPNT) United States $0.047B 101.00
GTx (ONCT) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
PolarityTE (PTE) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.037B 7.02
Adamis Pharmaceuticals (ADMP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Novan (NOVN) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Addex Therapeutics (ADXN) Switzerland $0.000B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00